CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,390 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06115681
NCT06115681N/ACompleted
CompareCT.gov

Demographic, Clinical Characteristics, and Treatment Outcomes Associated With Dedifferentiated Liposarcoma Patients in China

Boehringer Ingelheim·observational·Posted Nov 3, 2023·Updated Jul 10, 2025

In Brief

An observational study for Dedifferentiated Liposarcoma. Completed, enrolled 1,390 participants across 1 site.

Detailed Summary

This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clinical outcomes associated with the current real-world treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDedifferentiated Liposarcoma
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedNov 3, 2023
Enrollment StartMar 13, 2024
Primary CompletionMay 15, 2024
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.7 years ago